HDAC9 and breast carcinoma: Moreover, our analysis of publicly available cDNA array data showed a significant increase in HDAC9 mRNA levels in ERα‐negative tumors compared with ERα‐positive samples, validating the biological relevance of the results obtained in breast cancer cell lines.